相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells
Christine Bourcier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
Tristetraprolin regulates the stability of HIF-1 alpha mRNA during prolonged hypoxia
Tae Woo Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Alternative splicing: good and bad effects of translationally silent substitutions
M. Raponi et al.
FEBS JOURNAL (2010)
Stability of the LATS2 Tumor Suppressor Gene Is Regulated by Tristetraprolin
Hyun Hee Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Silent mutations in sight: co-variations in tRNA abundance as a key to unravel consequences of silent mutations
Andreas Czech et al.
MOLECULAR BIOSYSTEMS (2010)
The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes
N. Al-Souhibani et al.
ONCOGENE (2010)
Translation efficiency is determined by both codon bias and folding energy
Tamir Tuller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer
Theresa Casey et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The mRNA-Destabilizing Protein Tristetraprolin Is Suppressed in Many Cancers, Altering Tumorigenic Phenotypes and Patient Prognosis
Sarah E. Brennan et al.
CANCER RESEARCH (2009)
Current perspective - Trastuzumab
Peter S. Hall et al.
EUROPEAN JOURNAL OF CANCER (2009)
Control of mRNA decay by phosphorylation of tristetraprolin
Heike Sandler et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells
Esther Suswam et al.
CANCER RESEARCH (2008)
Tristetraprolin regulates CXCL1 (KC) mRNA stability
Shyamasree Datta et al.
JOURNAL OF IMMUNOLOGY (2008)
Synonymous Mutations and Ribosome Stalling Can Lead to Altered Folding Pathways and Distinct Minima
Chung-Jung Tsai et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
An upstream open reading frame within an IRES controls expression of a specific VEGF-A isoform
Amandine Bastide et al.
NUCLEIC ACIDS RESEARCH (2008)
Tristetraprolin inhibits ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation
Khadija Essafi-Benkhadir et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Silent Polymorphisms speak: How they affect pharmacogenomics and the treatment of cancer
Zuben E. Sauna et al.
CANCER RESEARCH (2007)
Role of the HER2 [lle655Val] genetic polymorphism in tumorogenesis and in the risk of-trastuzumab-related cardiotoxicity
S. Beauclair et al.
ANNALS OF ONCOLOGY (2007)
A silent polymorphism in the MDR1 gene changes substrate specificity
Chava Kimchi-Sarfaty et al.
SCIENCE (2007)
Modulation of mRNA stability as a novel therapeutic approach
Wolfgang Eberhardt et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure
A. G. Nackley et al.
SCIENCE (2006)
Tristetraprolin regulates Cyclin D1 and c-myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling
M. Marderosian et al.
ONCOGENE (2006)
Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world
Farin Kamangar et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Genetic variations in ZFP36 and their possible relationship to autoimmune diseases
Danielle Mercatante Carrick et al.
JOURNAL OF AUTOIMMUNITY (2006)
Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways
M Brook et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
X chromosomal abnormalities in basal-like human breast cancer
AL Richardson et al.
CANCER CELL (2006)
Control of the vascular endothelial growth factor internal ribosome entry site (IRES) activity and translation initiation by alternatively spliced coding sequences
S Bornes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis
DM Carrick et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Involvement of ras activation in human breast cancer cell signaling, invasion, and anoikis
LB Eckert et al.
CANCER RESEARCH (2004)
Selective and mutational patterns associated with gene expression in humans: Influences on synonymous composition and intron presence
JM Comeron
GENETICS (2004)
Immunological characterization of tristetraprolin as a low abundance, inducible, stable cytosolic protein
HP Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Tristetraprolin binds to the 3′-untranslated region of cyclooxygenase-2 mRNA -: A polyadenylation variant in a cancer cell line lacks the binding site
H Sawaoka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor
JB Duan et al.
HUMAN MOLECULAR GENETICS (2003)
Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability
KR Mahtani et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
分享论文
